Journal of Applied Physiology, Vol 53, Issue 1 1-8, Copyright © 1982 by American Physiological Society

ARTICLES

Pulmonary surfactant

R. J. King

Pulmonary surfactant reduces the surface tension of the alveolar air-liquid interface, thereby providing mechanical stability and preventing alveolar atelectasis. More than 50% of surfactant is dipalmitoyl phosphatidylcholine, a material that is capable of reducing the surface tension of the alveolar interface to uniquely low values. The functions of the remaining 25% unsaturated phosphatidylcholines, 5-10% phosphatidylglycerol, 5% cholesterol, and 8-10% protein are unknown. Surfactant is synthesized by alveolar epithelial type II cells and is probably secreted as a lipoprotein complex. Lamellar bodies, which distinguish type II cells, are likely to be intracellular sites of transport of processing. The catabolism of surfactant after it is secreted into the alveolar lumen is complicated and involves different turnover times for the phosphatidylcholines, phosphatidylglycerol, and the proteins. The metabolic events are under hormonal control and may involve an interplay between beta-adrenergic agonists cAMP, and prostaglandins. In disease, such as the neonatal and adult respiratory distress syndromes, derangements in the metabolic processes may produce surfactant that is abnormal with respect to its chemical and physical properties.

This article has been cited by other articles:

				M. Seifert, D. Breitenstein, U. Klenz, M. C. Meyer, and H.-J. Galla Solubility versus Electrostatics: What Determines Lipid/Protein Interaction in Lung Surfactant Biophys. J., August 15, 2007; 93(4): 1192 - 1203. [Abstract] [Full Text] [PDF]

				S. R. Bates, J.-Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat Pulmonary abnormalities due to ABCA1 deficiency in mice Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L980 - L989. [Abstract] [Full Text] [PDF]

				A. E. Bortnick, E. Favari, J.-Q. Tao, O. L. Francone, M. Reilly, Y. Zhang, G. H. Rothblat, and S. R. Bates Identification and characterization of rodent ABCA1 in isolated type II pneumocytes Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L869 - L878. [Abstract] [Full Text] [PDF]

				C. J. Ormond, S. Orgeig, C. B. Daniels, and W. K. Milsom Thermal acclimation of surfactant secretion and its regulation by adrenergic and cholinergic agonists in type II cells isolated from warm-active and torpid golden-mantled ground squirrels, Spermophilus lateralis J. Exp. Biol., September 1, 2003; 206(17): 3031 - 3041. [Abstract] [Full Text] [PDF]

				E. Rosenberg, F. Li, C. I. Smith, S. R. Reisher, and S. I. Feinstein Transcriptional activation and protein binding by two regions of the rat surfactant protein A promoter Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L134 - L141. [Abstract] [Full Text] [PDF]

				C. HERMANS and A. BERNARD Lung Epithelium-specific Proteins . Characteristics and Potential Applications as Markers Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 646 - 678. [Full Text]

				M. F. Beers, C. A. Lomax, and S. J. Russo Synthetic Processing of Surfactant Protein C by Alevolar Epithelial Cells. THE COOH TERMINUS OF proSP-C IS REQUIRED FOR POST-TRANSLATIONAL TARGETING AND PROTEOLYSIS J. Biol. Chem., June 12, 1998; 273(24): 15287 - 15293. [Abstract] [Full Text] [PDF]

				M. E. ERASMUS, G. J. H. HOFSTEDE, A. H. PETERSEN, H. P. HAAGSMAN, S. B. OETOMO, and J. PROP Effects of Early Surfactant Treatment Persisting for One Week after Lung Transplantation in Rats Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 567 - 572. [Abstract] [Full Text]

				S L McKnight, M D Lane, and S Gluecksohn-Waelsch Is CCAAT/enhancer-binding protein a central regulator of energy metabolism? Genes & Dev., December 1, 1989; 3(12b): 2021 - 2024. [PDF]